Main menu

Unlocking the biopharma development pipeline with Oxford Nanopore


Introductory guide: biopharma — 2 pages

Overview

The current drug development process can be long, complex, and resource-intensive. One major bottleneck is the use of a compendium of conventional assays and analytical tools, which have inherent limitations that restrict efficiency, accuracy, scalability, and fast decision-making.

In this introductory guide, discover how a new generation of molecular sensing technology from Oxford Nanopore is transforming the biopharma development pipeline. Oxford Nanopore sequencing is a single-platform solution that is streamlining the process from discovery to clinical development:

  • Novel biomarker discovery and target identification
  • Candidate identification
  • Construct characterisation
  • Expression optimisation
  • Viral vector characterisation
  • Cell line development
  • Quality control release testing
  • Clinical development and post-market surveillance

Download

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag